- Home
- ATHA vs AMZE Comparison
ATHA vs AMZE Comparison
Compare ATHA & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- AMZE
- Stock Information
- Founded
- ATHA 2011
- AMZE 2019
- Country
- ATHA United States
- AMZE United States
- Employees
- ATHA N/A
- AMZE N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- AMZE Beverages (Production/Distribution)
- Sector
- ATHA Health Care
- AMZE Consumer Staples
- Exchange
- ATHA Nasdaq
- AMZE Nasdaq
- Market Cap
- ATHA 14.8M
- AMZE 16.1M
- IPO Year
- ATHA 2020
- AMZE 2021
- Fundamental
- Price
- ATHA $0.36
- AMZE $2.78
- Analyst Decision
- ATHA Hold
- AMZE
- Analyst Count
- ATHA 3
- AMZE 0
- Target Price
- ATHA $0.50
- AMZE N/A
- AVG Volume (30 Days)
- ATHA 159.8K
- AMZE 49.8K
- Earning Date
- ATHA 11-06-2025
- AMZE 11-13-2025
- Dividend Yield
- ATHA N/A
- AMZE N/A
- EPS Growth
- ATHA N/A
- AMZE N/A
- EPS
- ATHA N/A
- AMZE N/A
- Revenue
- ATHA N/A
- AMZE $1,054,111.00
- Revenue This Year
- ATHA N/A
- AMZE $6,741.66
- Revenue Next Year
- ATHA N/A
- AMZE $100.61
- P/E Ratio
- ATHA N/A
- AMZE N/A
- Revenue Growth
- ATHA N/A
- AMZE N/A
- 52 Week Low
- ATHA $0.22
- AMZE $1.57
- 52 Week High
- ATHA $0.83
- AMZE $28.72
- Technical
- Relative Strength Index (RSI)
- ATHA 36.59
- AMZE 43.60
- Support Level
- ATHA $0.35
- AMZE $1.57
- Resistance Level
- ATHA $0.40
- AMZE $2.68
- Average True Range (ATR)
- ATHA 0.02
- AMZE 0.35
- MACD
- ATHA -0.00
- AMZE 0.14
- Stochastic Oscillator
- ATHA 11.86
- AMZE 72.89
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.